Carelabs Co

Carelabs Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Carelabs Co (263700.KQ) as of Oct 25, 2026 is 23.79 B KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -15.46 B KRW — a change of -253.92% (higher).

EBITDA

23.79 BKRW

YoY

-253.92%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Carelabs Co is 2025 23.79 B KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Carelabs Co was 2024 -15.46 B KRW. It decreases by -253.92% higher compared to the previous year.

The Carelabs Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2016
2.18 B KRW
Jan 1, 2017
6.86 B KRW
Jan 1, 2018
6.28 B KRW
Jan 1, 2019
4.49 B KRW
Jan 1, 2020
8.33 B KRW
Jan 1, 2021
7.81 B KRW
Jan 1, 2023
-15.46 B KRW
Jan 1, 2025
23.79 B KRW
The Carelabs Co EBITDA history
YEAREBITDAYoY
23.79 BKRW-253.92%
-15.46 BKRW-297.89%
7.81 BKRW-6.22%
8.33 BKRW+85.29%
4.49 BKRW-28.39%
6.28 BKRW-8.47%
6.86 BKRW+214.96%
2.18 BKRW+64.05%
1.33 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Carelabs Co Stock analysis

What does Carelabs Co do? Carelabs Co., Ltd. generates revenue through three business segments. The Healthcare Digital Marketing segment offers marketing planning, production, and agency services. The Healthcare Media Platform segment provides hospital pharmacy search services and community apps under the brands GOODOC and BABITALK. The Healthcare Solution segment sells CRM software, prescription security systems, and pharmacy billing programs. Domestic and overseas markets purchase these products and services, with GOODOC and BABITALK being key brand names in the media platform segment. The company's primary customers are healthcare institutions and businesses seeking digital marketing and media solutions. GOODOC and BABITALK serve as the main platforms for beauty care community apps and pharmacy search services. The Healthcare Solution segment targets pharmacies and hospitals needing CRM and billing systems. All products are distributed domestically and internationally without specifying additional market details. Carelabs Co., Ltd. focuses on delivering software and content services within the healthcare sector. The brand names GOODOC and BABITALK are central to the Healthcare Media Platform segment, while CRM software and pharmacy billing programs drive the Healthcare Solution segment. Domestic and overseas markets represent the key customer segments for all three business areas. Carelabs Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Carelabs Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Carelabs Co is 23.79 B KRW in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Carelabs Co changed from -15.46 B KRW to 23.79 B KRW, representing a -253.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Carelabs Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Carelabs Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Carelabs Co

All Key Metrics — Carelabs Co